The following is a summary of “Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature review,” published in the May 2025 issue of BMC Nephrology ...

The queen is dead. It took three straight titles and 26 consecutive match wins at Roland-Garros for Iga Swiatek to finally lose on the Parisian clay. Aryna Sabalenka deservedly got the scalp, ...

(Otsuka) today presented results from a pre-specified interim analysis of the Phase 3 VISIONARY study (NCT05248646) evaluating sibeprenlimab, for the treatment of immunoglobulin A nephropathy ...

In the Phase 3 VISIONARY study, sibeprenlimab achieved a statistically significant and clinically meaningful 51.2% (P<0.0001) reduction in proteinuria at nine months of treatment when compared to ...

PARIS (AP) — No. 1 Aryna Sabalenka ends Iga Swiatek’s 26-match French Open winning streak and reaches the final.

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease ...

On Thursday afternoon, Aryna Sabalenka defeated Iga Swiatek in three sets in the French Open semifinals: 7-6, 4-6, 6-0. The loss ended Swiatek's title defense, 26-match win streak at Roland Garros ...

Barratt. Treatment also led to sustained reductions in serum immunoglobulins, including a 74% drop in IgA and pathogenic Gd-IgA1, consistent with APRIL pathway inhibition. Zigakibart was well ...

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, reinforce its potential as a disease-modifying ...